Article Text

PDF
Effect of tulathromycin on the carrier status of Actinobacillus pleuropneumoniae serotype 2 in the tonsils of pigs
  1. Ø. Angen, DVM, PhD1,
  2. M. Andreasen, DVM, PhD2,
  3. E. O. Nielsen, DVM, PhD3,
  4. A. Stockmarr, MSc, PhD1 and
  5. P. Bækbo, DVM, PhD3
  1. 1 National Veterinary Institute, Technical University of Denmark, Bülowsvej 27, DK-1790 Copenhagen, Denmark
  2. 2 Orion Pharma Animal Health, Møllevej 9A, DK-2990 Nivå, Denmark
  3. 3 Danish Pig Production, Danish Meat Association, Vinkelvej 11, DK-8620 Kjellerup, Denmark

Abstract

The effect of a single or double dose of tulathromycin was evaluated in pigs carrying Actinobacillus pleuropneumoniae serotype 2 in their tonsils. Twenty-nine pigs from a reinfected specific pathogen-free-herd were selected from animals testing positive in an A pleuropneumoniae serotype 2-specific pcr test on tonsil scrapings and they were divided into three groups. The pigs in group 1 were treated subcutaneously with 2·5 mg/kg tulathromycin on day 0, the pigs in group 2 were treated with 2·5 mg/kg tulathromycin on days 0 and 4, and the pigs in group 3 were left untreated as controls. The pigs were tested by pcr on tonsil scrapings on days 0, 4, 11 and 33, and on day 33 all the animals were euthanased. There were no significant differences between the numbers of pcr-positive animals in the three groups on any of the sampling dates.

    Statistics from Altmetric.com

    Request permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.